产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF6012, RRID:AB_2834946.
展开/折叠
chuk; CHUK1; Conserved Helix Loop Helix Ubiquitous Kinase; Conserved helix loop ubiquitous kinase; Conserved helix-loop-helix ubiquitous kinase; I Kappa B Kinase 1; I Kappa B Kinase Alpha; I-kappa-B kinase 1; I-kappa-B kinase alpha; IkappaB kinase; IkB kinase alpha subunit; IkBKA; IKK 1; IKK A; IKK a kinase; IKK-A; IKK-alpha; IKK1; IKKA; IKKA_HUMAN; Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B Cells; Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit; Inhibitor of nuclear factor kappa-B kinase subunit alpha; NFKBIKA; Nuclear Factor Kappa B Inhibitor Kinase Alpha; Nuclear factor NF kappa B inhibitor kinase alpha; Nuclear factor NF-kappa-B inhibitor kinase alpha; Nuclear factor NFkappaB inhibitor kinase alpha; Nuclear Factor Of Kappa Light Chain Gene Enhancer In B Cells Inhibitor; TCF-16; TCF16; Transcription factor 16;
抗原和靶标
- O15111 IKKA_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGSLCTSFVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPKCIFACEEMSGEVRFSSHLPQPNSLCSLVVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGISLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPIIQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKLEFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAEIMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRVLKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQSSARSLVGSSLEGAVTPQTSAWLPPTSAEHDHSLSCVVTPQDGETSAQMIEENLNCLGHLSTIIHEANEEQGNSMMNLDWSWLTE
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - O15111 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
T23 | Phosphorylation | Q9Y243 (AKT3) , O00141 (SGK1) , P31749 (AKT1) , P31751 (AKT2) | Uniprot |
K44 | Ubiquitination | Uniprot | |
K53 | Ubiquitination | Uniprot | |
K67 | Ubiquitination | Uniprot | |
K105 | Ubiquitination | Uniprot | |
K109 | Ubiquitination | Uniprot | |
K117 | Ubiquitination | Uniprot | |
S119 | Acetylation | Uniprot | |
K139 | Ubiquitination | Uniprot | |
K146 | Ubiquitination | Uniprot | |
K158 | Ubiquitination | Uniprot | |
Y168 | Phosphorylation | Uniprot | |
S176 | Phosphorylation | Q04759 (PRKCQ) , Q99558 (MAP3K14) | Uniprot |
T179 | Acetylation | Uniprot | |
S180 | Phosphorylation | Q04759 (PRKCQ) , Q99558 (MAP3K14) | Uniprot |
K296 | Ubiquitination | Uniprot | |
K322 | Acetylation | Uniprot | |
K366 | Ubiquitination | Uniprot | |
K391 | Ubiquitination | Uniprot | |
K415 | Ubiquitination | Uniprot | |
K438 | Acetylation | Uniprot | |
T463 | Phosphorylation | Uniprot | |
S473 | Phosphorylation | Q13315 (ATM) | Uniprot |
Y500 | Phosphorylation | Uniprot | |
K506 | Ubiquitination | Uniprot | |
S536 | Phosphorylation | Uniprot | |
K569 | Ubiquitination | Uniprot | |
K572 | Ubiquitination | Uniprot | |
S576 | Phosphorylation | Uniprot | |
T593 | Phosphorylation | Uniprot | |
K602 | Ubiquitination | Uniprot | |
K615 | Ubiquitination | Uniprot | |
K617 | Ubiquitination | Uniprot | |
K624 | Ubiquitination | Uniprot | |
T722 | Acetylation | Uniprot |
翻译修饰 - O15111 作为激酶
Substrate | Site | Source |
---|---|---|
O14920-1 (IKBKB) | S177 | Uniprot |
O14920-1 (IKBKB) | S181 | Uniprot |
O43524 (FOXO3) | S644 | Uniprot |
O75925-1 (PIAS1) | S90 | Uniprot |
P03372 (ESR1) | S118 | Uniprot |
P19838-2 (NFKB1) | S922 | Uniprot |
P19838 (NFKB1) | S923 | Uniprot |
P19838-2 (NFKB1) | S924 | Uniprot |
P19838 (NFKB1) | S927 | Uniprot |
P19838-2 (NFKB1) | S928 | Uniprot |
P19838 (NFKB1) | T931 | Uniprot |
P19838 (NFKB1) | S932 | Uniprot |
P19838-2 (NFKB1) | T932 | Uniprot |
P19838-2 (NFKB1) | S933 | Uniprot |
P24385 (CCND1) | T286 | Uniprot |
P25963 (NFKBIA) | S32 | Uniprot |
P25963 (NFKBIA) | S36 | Uniprot |
P35222 (CTNNB1) | S33 | Uniprot |
P35222 (CTNNB1) | S37 | Uniprot |
P35222 (CTNNB1) | T41 | Uniprot |
P35222 (CTNNB1) | S45 | Uniprot |
P42345 (MTOR) | S1415 | Uniprot |
P84243 (H3F3B) | S11 | Uniprot |
Q00653 (NFKB2) | S99 | Uniprot |
Q00653 (NFKB2) | S108 | Uniprot |
Q00653 (NFKB2) | S115 | Uniprot |
Q00653 (NFKB2) | S123 | Uniprot |
Q00653 (NFKB2) | S872 | Uniprot |
Q01094 (E2F1) | S403 | Uniprot |
Q01201 (RELB) | S472 | Uniprot |
Q04206 (RELA) | S536 | Uniprot |
Q04864 (REL) | S557 | Uniprot |
Q14164 (IKBKE) | S172 | Uniprot |
Q15653-1 (NFKBIB) | S19 | Uniprot |
Q15653-1 (NFKBIB) | S23 | Uniprot |
Q15717 (ELAVL1) | S304 | Uniprot |
Q5S007 (LRRK2) | S910 | Uniprot |
Q5S007 (LRRK2) | S935 | Uniprot |
Q86VP1-2 (TAX1BP1) | S593 | Uniprot |
Q86VP1-2 (TAX1BP1) | S624 | Uniprot |
Q86VP1 (TAX1BP1) | S666 | Uniprot |
Q92793 (CREBBP) | S1382 | Uniprot |
Q92793 (CREBBP) | S1386 | Uniprot |
Q99558 (MAP3K14) | T559 | Uniprot |
Q9BUZ4 (TRAF4) | S426 | Uniprot |
Q9BXH1 (BBC3) | S10 | Uniprot |
Q9NQC7 (CYLD) | S418 | Uniprot |
Q9NQC7 (CYLD) | S422 | Uniprot |
Q9NQC7 (CYLD) | S432 | Uniprot |
Q9NQC7 (CYLD) | S436 | Uniprot |
Q9NQC7 (CYLD) | S439 | Uniprot |
Q9NQC7 (CYLD) | S441 | Uniprot |
Q9NQC7 (CYLD) | S444 | Uniprot |
Q9Y261 (FOXA2) | S107 | Uniprot |
Q9Y261 (FOXA2) | S111 | Uniprot |
Q9Y6Q9-5 (NCOA3) | S857 | Uniprot |
研究背景
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities. Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP. Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor. Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity).
Phosphorylated by MAP3K14/NIK, AKT and to a lesser extent by MEKK1, and dephosphorylated by PP2A. Autophosphorylated.
(Microbial infection) Acetylation of Thr-179 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the I-kappa-B signaling pathway.
Cytoplasm. Nucleus.
Note: Shuttles between the cytoplasm and the nucleus.
Widely expressed.
Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex. The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65 (By similarity). Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Part of a 70-90 kDa complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA, ELP1 and MAP3K14. Directly interacts with TRPC4AP (By similarity). May interact with TRAF2. Interacts with NALP2. May interact with MAVS/IPS1. Interacts with ARRB1 and ARRB2. Interacts with NLRC5; prevents CHUK phosphorylation and kinase activity. Interacts with PIAS1; this interaction induces PIAS1 phosphorylation. Interacts with ZNF268 isoform 2; the interaction is further increased in a TNF-alpha-dependent manner. Interacts with FOXO3. Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation. Interacts with LRRC14. Interacts with SASH1.
(Microbial infection) Interacts with InlC of Listeria monocytogenes.
The kinase domain is located in the N-terminal region. The leucine zipper is important to allow homo- and hetero-dimerization. At the C-terminal region is located the region responsible for the interaction with NEMO/IKBKG.
Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.
研究领域
· Cellular Processes > Cell growth and death > Apoptosis. (View pathway)
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > FoxO signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > mTOR signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > TNF signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > Antifolate resistance.
· Human Diseases > Infectious diseases: Bacterial > Epithelial cell signaling in Helicobacter pylori infection.
· Human Diseases > Infectious diseases: Bacterial > Shigellosis.
· Human Diseases > Infectious diseases: Parasitic > Chagas disease (American trypanosomiasis).
· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.
· Human Diseases > Infectious diseases: Viral > Hepatitis C.
· Human Diseases > Infectious diseases: Viral > Hepatitis B.
· Human Diseases > Infectious diseases: Viral > Measles.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Infectious diseases: Viral > HTLV-I infection.
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Pancreatic cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Prostate cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia. (View pathway)
· Human Diseases > Cancers: Specific types > Acute myeloid leukemia. (View pathway)
· Human Diseases > Cancers: Specific types > Small cell lung cancer. (View pathway)
· Organismal Systems > Immune system > Chemokine signaling pathway. (View pathway)
· Organismal Systems > Development > Osteoclast differentiation. (View pathway)
· Organismal Systems > Immune system > Toll-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > NOD-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > Cytosolic DNA-sensing pathway. (View pathway)
· Organismal Systems > Immune system > IL-17 signaling pathway. (View pathway)
· Organismal Systems > Immune system > Th1 and Th2 cell differentiation. (View pathway)
· Organismal Systems > Immune system > Th17 cell differentiation. (View pathway)
· Organismal Systems > Immune system > T cell receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > B cell receptor signaling pathway. (View pathway)
· Organismal Systems > Endocrine system > Adipocytokine signaling pathway.
文献引用
Application: WB Species: Human Sample: NPC cells
Application: WB Species: human Sample: HUVECs cells
Application: WB Species: Rat Sample: UUO group rats
Application: WB Species: Human Sample: podocytes
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.